All In Biotech

Drug Trial Radar · NCT00616655

Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects

A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.

Last checked: Nov 20, 2026Latest source record: Apr 8, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 456 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

456

Actual

Start

Jan 2008

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Sumitomo Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Feb 15, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the safety and efficacy of SEP-225441 (eszopiclone) in subjects with generalized anxiety disorder (GAD).

Conditions

  • Generalized Anxiety Disorder

Interventions

  • eszopicloneDrug

    SEP-225441 (eszopiclone) total daily dose of 1.5 mg

  • eszopicloneDrug

    SEP-225441 (eszopiclone) total daily dose of 0.9 mg

  • PlaceboDrug

    Placebo total daily dose 0.9 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 8 in the Total Score on the Hamilton Anxiety Scale (HAM-A), as Assessed by the Site-trained RaterTime frame: Baseline to Week 8

Locations

57 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham Psychiatry Pharaceutical Studies, Inc.

    Birmingham, Alabama

  • Site not named

    Arcadia, California

  • Southwestern Research, Inc.

    Beverly Hills, California

  • Southwestern Research, Inc.

    Burbank, California

  • California Clinical Trials Medical Group

    Glendale, California

  • California clinical Trials Medical Group

    Glendale, California

  • Site not named

    Newport Beach, California

  • Excell Research

    Oceanside, California

  • California Clinical Trials Medical Group

    Paramount, California

  • Southwestern Research, Inc.

    Pasadena, California

  • California clinical Trials Medical Group

    San Diego, California

  • Stanford Universtiy Medical center

    Stanford, California

  • University of CT Health Center

    Farmington, Connecticut

  • Comprehensive Psychiatric Care, PC

    Norwich, Connecticut

  • Florida Clinical Research Center LLC

    Bradenton, Florida

  • Sarkis Clinical Trials

    Gainsville, Florida

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Comprehensive NeuroScience, Inc.

    St. Petersburg, Florida

  • Stedman Clinical Trials, LLC

    Tampa, Florida

  • Janus Center for Psychiatric Research

    West Palm Beach, Florida

  • Comprehensive NeuroScience, Inc.

    Atlanta, Georgia

  • Carmen Research

    Smyrna, Georgia

  • Alexian Brothers Center for Psychiatric Research

    Hoffman Estates, Illinois

  • Comprehensive NeuroScience, Inc.

    Park Ridge, Illinois

  • Vince and Associats Clinical Research

    Overland Park, Kansas

  • Clinical Trials Technology, Inc.

    Prairie Village, Kansas

  • Pedia Research, LLC

    Owensboro, Kentucky

  • Pharasite Research, Inc.

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Coastal Research Associates, Inc.

    Braintree, Massachusetts

  • Center for Emotional Fitness

    Cherry Hill, New Jersey

  • CRI Worldwide, LLC

    Clementon, New Jersey

  • Social Psychiatry Research Institute

    Brooklyn, New York

  • Neurobehavioral Research, Inc.

    Cedarhurst, New York

  • Comprehensive NeuroScience, Inc.

    Fresh Meadows, New York

  • Fieve Clinica Services, Inc.

    New York, New York

  • Medical & Behavioral Health Research, PC

    New York, New York

  • Medical & Behavioral Health Research, P.C.

    New York, New York

  • Richmond Behavioral Associates

    Staten Island, New York

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.